CELC Celcuity Corp: Rasio Kapitalisasi Pasar marang Nilai Buku

The asset value of Celcuity Inc. (CELC), which currently stands at -255.26 as shown on the chart, is subject to global instability hindering the supply of research components. Cohesive leadership advancing oncology therapy supports the stability of the quotes. The business relies on external contractors for testing, prioritizing internal developments in cell analysis.

Celcuity Inc. (CELC) - Rasio Kapitalisasi Pasar marang Nilai Buku saka 04.07.2022 nganti 27.10.2026

CELC (Celcuity Inc): rincian analitis lan laporan miturut indikator

- rega lan prakiraan konsensus rega:

Rega saham Celcuity Inc.|CELC - Target konsensus

- data kapitalisasi pasar:

Kapitalisasi pasar Celcuity Corp|CELC - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Celcuity|CELC - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku celcuity.com|CELC - Total Aset Bisnis

- data utang lan likuiditas:

Total Utang marang Modal Celcuity Inc.|CELC - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Celcuity Corp|CELC - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Celcuity Corp

Pambiji fundamental:CELC (Celcuity Inc.)

The price-to-book ratio, expressing the relationship between market value and equity, determines the premium investors are willing to pay for the net assets of Celcuity Inc. (CELC). The current value of -255.26 reflects market expectations for the unique live drug testing platform and the company's pricing power within the inelastic oncology diagnostics segment, which is clearly evidenced by the history of the company's P/BV ratio.

Pesaing utama